Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7606 AL 7620

Carbon nanomaterials for tau targeting in Alzheimer's disease: Theranostic strategies and clinical prospects

Muthuramalingam K, Lee HJ.

J Alzheimers Dis. 2026 Feb;109(4):1558-1573. doi: 10.1177/13872877251407702. Epub 2025 Dec 19.

Antibody drug conjugates in Alzheimer's disease: emerging strategies and future directions

AmeliMojarad M, AmeliMojarad M.

Neuroscience. 2026 Mar 5;596:45-53. doi: 10.1016/j.neuroscience.2025.12.053. Epub 2025 Dec 20.

Guardians of homeostasis: Natural products target metabolic reprogramming in Alzheimer's disease

Zhang Z, Xu H, Zhao F, Han Z, Pan J, Li M, Guan W, Jiang P, Hao Z, Zhang Y, Ma X, Kuang H, Liu Y.

Ageing Res Rev. 2026 Jan;114:103005. doi: 10.1016/j.arr.2025.103005. Epub 2025 Dec 24.

Antimicrobial peptides inhibit Tau aggregation and modulates its pathology

Chinnathambi S, Rangappa N, Malik S.

Adv Protein Chem Struct Biol. 2026;149:375-394. doi: 10.1016/bs.apcsb.2025.09.002. Epub 2025 Oct 8.

Clinical Trials of Cell Products for the Treatment of Alzheimer's Disease (Review)

Voronova AD, Karsuntseva EK, Shishkina VS, Chadin AV, Fursa GA, Gurin PI, Kuznetsova TV, Reshetov IV, Shport SV, Stepanova OV, Chekhonin VP.

Bull Exp Biol Med. 2025 Nov;180(1):112-118. doi: 10.1007/s10517-026-06590-4. Epub 2026 Feb 10.

Antibodies targeting amyloid-β and Tau oligomers in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;151:225-265. doi: 10.1016/bs.apcsb.2025.10.002. Epub 2025 Nov 5.

Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease Dementia

Singhal T, Cicero S, Gale SA, Horan N, Dubey S, Marshall GA, Weiner HL.

Clin Nucl Med. 2025 Aug 1;50(8):756-757. doi: 10.1097/RLU.0000000000005955. Epub 2025 May 13.

Multiple ischemic strokes in a patient treated with Lecanemab: a case report

Alammar H, Diallo M, Llano DA.

Neurocase. 2025 Dec;31(6):295-300. doi: 10.1080/13554794.2025.2566151. Epub 2025 Oct 16.

Comparison of treatment schedules on cognitive effects of rTMS in the 3xTg-AD model of Alzheimer's disease

Heath AM, Mojabi FS, Kraybill EP, Beard C, Venkataramanan V, Cuéllar V, Piekarski D, McNerney MW.

Exp Neurol. 2026 Feb;396:115551. doi: 10.1016/j.expneurol.2025.115551. Epub 2025 Nov 12.

Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer's activity in aluminum chloride-induced Alzheimer's-like disease in rats: Impact on α7 nicotinic acetylcholine receptors and amyloid β

Abdel-Aal RA, Meligy FY, Maghraby N, Sayed N, Mohamed Ashry IE.

Brain Res. 2025 May 15;1855:149573. doi: 10.1016/j.brainres.2025.149573. Epub 2025 Mar 15.

Comparing Emotional Valence from Human Quantitative Ratings and Qualitative Narrative Data on Using Artificial Intelligence to Reduce Caregiving Disparity

Yoon S, Crupi R, Sun F, Tipiani D, Patterson M, Pottinger T, Kim M, Davis N.

Stud Health Technol Inform. 2025 Apr 8;323:1-5. doi: 10.3233/SHTI250036.

Comparing clinical effect sizes of Souvenaid(TM), lecanemab, and donanemab in early Alzheimer's disease

Solfrizzi V, Imbimbo BP.

J Alzheimers Dis. 2026 Feb;109(3):1258-1263. doi: 10.1177/13872877251406221. Epub 2025 Dec 22.

Deep cervical lymphaticovenous anastomosis in Alzheimer's disease: A promising frontier or premature enthusiasm?

Ma YN, Wang Z, Tang W.

Biosci Trends. 2025 May 9;19(2):144-149. doi: 10.5582/bst.2025.01108. Epub 2025 Apr 15.

Clinical trials targeting tau should be halted

Olluri A.

J Clin Neurosci. 2025 Apr;134:111101. doi: 10.1016/j.jocn.2025.111101. Epub 2025 Feb 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias